nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—ACE—prostate cancer	0.62	1	CbGaD
Quinapril—ACE—urine—prostate cancer	0.00898	0.208	CbGeAlD
Quinapril—SLC15A1—epithelium—prostate cancer	0.0033	0.0764	CbGeAlD
Quinapril—ACE—prostate gland—prostate cancer	0.00322	0.0745	CbGeAlD
Quinapril—SLC15A1—renal system—prostate cancer	0.00306	0.0709	CbGeAlD
Quinapril—SLC15A2—prostate gland—prostate cancer	0.00281	0.065	CbGeAlD
Quinapril—ACE—seminal vesicle—prostate cancer	0.00273	0.063	CbGeAlD
Quinapril—SLC15A2—seminal vesicle—prostate cancer	0.00238	0.055	CbGeAlD
Quinapril—ACE—epithelium—prostate cancer	0.00237	0.0548	CbGeAlD
Quinapril—ACE—renal system—prostate cancer	0.0022	0.0508	CbGeAlD
Quinapril—ACE—urethra—prostate cancer	0.00216	0.0499	CbGeAlD
Quinapril—SLC15A2—renal system—prostate cancer	0.00192	0.0443	CbGeAlD
Quinapril—SLC15A2—urethra—prostate cancer	0.00188	0.0435	CbGeAlD
Quinapril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—prostate cancer	0.00177	0.0891	CbGpPWpGaD
Quinapril—ACE—bone marrow—prostate cancer	0.00166	0.0384	CbGeAlD
Quinapril—ACE—testis—prostate cancer	0.00142	0.0328	CbGeAlD
Quinapril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—prostate cancer	0.00129	0.0647	CbGpPWpGaD
Quinapril—SLC15A2—testis—prostate cancer	0.00124	0.0286	CbGeAlD
Quinapril—ACE—lymph node—prostate cancer	0.00103	0.0238	CbGeAlD
Quinapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A1—prostate cancer	0.000984	0.0495	CbGpPWpGaD
Quinapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A1—prostate cancer	0.000914	0.0459	CbGpPWpGaD
Quinapril—SLC15A2—lymph node—prostate cancer	0.000897	0.0208	CbGeAlD
Quinapril—Perindopril—ACE—prostate cancer	0.000584	0.093	CrCbGaD
Quinapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.00058	0.0291	CbGpPWpGaD
Quinapril—Spirapril—ACE—prostate cancer	0.000578	0.0919	CrCbGaD
Quinapril—Moexipril—ACE—prostate cancer	0.000554	0.0881	CrCbGaD
Quinapril—Benazepril—MTHFR—prostate cancer	0.00055	0.0875	CrCbGaD
Quinapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.000538	0.027	CbGpPWpGaD
Quinapril—Cilazapril—ACE—prostate cancer	0.000515	0.0819	CrCbGaD
Quinapril—Lisinopril—ACE—prostate cancer	0.000515	0.0819	CrCbGaD
Quinapril—ACE—ACE Inhibitor Pathway—NOS3—prostate cancer	0.000508	0.0255	CbGpPWpGaD
Quinapril—Ramipril—ACE—prostate cancer	0.000499	0.0794	CrCbGaD
Quinapril—Trandolapril—ACE—prostate cancer	0.000499	0.0794	CrCbGaD
Quinapril—ACE—Peptide hormone metabolism—MME—prostate cancer	0.000466	0.0234	CbGpPWpGaD
Quinapril—Benazepril—ACE—prostate cancer	0.000448	0.0713	CrCbGaD
Quinapril—ACE—Peptide hormone metabolism—GRP—prostate cancer	0.000446	0.0224	CbGpPWpGaD
Quinapril—Enalapril—ACE—prostate cancer	0.000378	0.0601	CrCbGaD
Quinapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.000364	0.0183	CbGpPWpGaD
Quinapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.000364	0.0183	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—ACHE—prostate cancer	0.000357	0.018	CbGpPWpGaD
Quinapril—Labetalol—ADRB2—prostate cancer	0.000341	0.0542	CrCbGaD
Quinapril—ACE—Peptide hormone metabolism—CTSD—prostate cancer	0.000338	0.017	CbGpPWpGaD
Quinapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.000338	0.017	CbGpPWpGaD
Quinapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.000338	0.017	CbGpPWpGaD
Quinapril—ACE—ACE Inhibitor Pathway—TGFB1—prostate cancer	0.000336	0.0169	CbGpPWpGaD
Quinapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—prostate cancer	0.000298	0.015	CbGpPWpGaD
Quinapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—prostate cancer	0.000277	0.0139	CbGpPWpGaD
Quinapril—Fentanyl—CYP3A5—prostate cancer	0.00027	0.043	CrCbGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000259	0.013	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.00024	0.0121	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—TUSC3—prostate cancer	0.000235	0.0118	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—IGFBP6—prostate cancer	0.000235	0.0118	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—SSR2—prostate cancer	0.00021	0.0105	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—GALNT3—prostate cancer	0.00021	0.0105	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000205	0.0103	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—SPON2—prostate cancer	0.000192	0.00963	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—HERPUD1—prostate cancer	0.000192	0.00963	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.00019	0.00955	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—LEP—prostate cancer	0.000187	0.00941	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—KLK3—prostate cancer	0.000178	0.00895	CbGpPWpGaD
Quinapril—Enalapril—CYP3A4—prostate cancer	0.000178	0.0282	CrCbGaD
Quinapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000176	0.00882	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—KLK2—prostate cancer	0.000168	0.00842	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—RPN2—prostate cancer	0.000168	0.00842	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—MBTPS1—prostate cancer	0.000168	0.00842	CbGpPWpGaD
Quinapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000163	0.00819	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000163	0.00817	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000163	0.00817	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—INS—prostate cancer	0.00016	0.00804	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—TCP1—prostate cancer	0.000159	0.00798	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—IGF1—prostate cancer	0.000155	0.00778	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—DNAJC3—prostate cancer	0.000151	0.00761	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000151	0.00758	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000151	0.00758	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—GCNT1—prostate cancer	0.000145	0.0073	CbGpPWpGaD
Quinapril—Propafenone—CYP3A4—prostate cancer	0.000143	0.0227	CrCbGaD
Quinapril—ACE—Metabolism of proteins—PDIA3—prostate cancer	0.00014	0.00702	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—EIF3H—prostate cancer	0.000135	0.00678	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—TPP1—prostate cancer	0.000135	0.00678	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—B4GALT4—prostate cancer	0.000135	0.00678	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000132	0.00663	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000132	0.00661	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—F9—prostate cancer	0.000131	0.00657	CbGpPWpGaD
Quinapril—Chest pain—Capecitabine—prostate cancer	0.000129	0.000416	CcSEcCtD
Quinapril—Myalgia—Capecitabine—prostate cancer	0.000129	0.000416	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000128	0.000413	CcSEcCtD
Quinapril—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000128	0.000413	CcSEcCtD
Quinapril—Hepatobiliary disease—Epirubicin—prostate cancer	0.000128	0.000412	CcSEcCtD
Quinapril—Anaphylactic shock—Docetaxel—prostate cancer	0.000128	0.000412	CcSEcCtD
Quinapril—Oedema—Docetaxel—prostate cancer	0.000128	0.000412	CcSEcCtD
Quinapril—Discomfort—Capecitabine—prostate cancer	0.000128	0.000411	CcSEcCtD
Quinapril—Infection—Docetaxel—prostate cancer	0.000127	0.000409	CcSEcCtD
Quinapril—Feeling abnormal—Etoposide—prostate cancer	0.000127	0.000408	CcSEcCtD
Quinapril—Diarrhoea—Mitoxantrone—prostate cancer	0.000127	0.000408	CcSEcCtD
Quinapril—Dry mouth—Capecitabine—prostate cancer	0.000126	0.000407	CcSEcCtD
Quinapril—Vomiting—Estradiol—prostate cancer	0.000126	0.000407	CcSEcCtD
Quinapril—Agranulocytosis—Epirubicin—prostate cancer	0.000126	0.000407	CcSEcCtD
Quinapril—Gastrointestinal pain—Etoposide—prostate cancer	0.000126	0.000405	CcSEcCtD
Quinapril—Shock—Docetaxel—prostate cancer	0.000126	0.000405	CcSEcCtD
Quinapril—Nervous system disorder—Docetaxel—prostate cancer	0.000125	0.000404	CcSEcCtD
Quinapril—Ill-defined disorder—Prednisone—prostate cancer	0.000125	0.000404	CcSEcCtD
Quinapril—Thrombocytopenia—Docetaxel—prostate cancer	0.000125	0.000403	CcSEcCtD
Quinapril—Rash—Estradiol—prostate cancer	0.000125	0.000403	CcSEcCtD
Quinapril—Infestation NOS—Doxorubicin—prostate cancer	0.000125	0.000403	CcSEcCtD
Quinapril—Infestation—Doxorubicin—prostate cancer	0.000125	0.000403	CcSEcCtD
Quinapril—Dermatitis—Estradiol—prostate cancer	0.000125	0.000403	CcSEcCtD
Quinapril—Tachycardia—Docetaxel—prostate cancer	0.000125	0.000402	CcSEcCtD
Quinapril—Headache—Estradiol—prostate cancer	0.000124	0.000401	CcSEcCtD
Quinapril—Skin disorder—Docetaxel—prostate cancer	0.000124	0.0004	CcSEcCtD
Quinapril—Oedema—Capecitabine—prostate cancer	0.000124	0.000399	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—MUC4—prostate cancer	0.000123	0.00621	CbGpPWpGaD
Quinapril—Angioedema—Prednisone—prostate cancer	0.000123	0.000398	CcSEcCtD
Quinapril—Renal failure—Doxorubicin—prostate cancer	0.000123	0.000396	CcSEcCtD
Quinapril—Infection—Capecitabine—prostate cancer	0.000123	0.000396	CcSEcCtD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000122	0.00615	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000122	0.00614	CbGpPWpGaD
Quinapril—Malaise—Prednisone—prostate cancer	0.000122	0.000393	CcSEcCtD
Quinapril—Shock—Capecitabine—prostate cancer	0.000122	0.000392	CcSEcCtD
Quinapril—Abdominal pain—Etoposide—prostate cancer	0.000122	0.000392	CcSEcCtD
Quinapril—Urinary tract infection—Doxorubicin—prostate cancer	0.000122	0.000392	CcSEcCtD
Quinapril—Nervous system disorder—Capecitabine—prostate cancer	0.000121	0.000391	CcSEcCtD
Quinapril—Vertigo—Prednisone—prostate cancer	0.000121	0.000391	CcSEcCtD
Quinapril—Hepatitis—Epirubicin—prostate cancer	0.000121	0.000391	CcSEcCtD
Quinapril—Thrombocytopenia—Capecitabine—prostate cancer	0.000121	0.000391	CcSEcCtD
Quinapril—Syncope—Prednisone—prostate cancer	0.000121	0.00039	CcSEcCtD
Quinapril—Tachycardia—Capecitabine—prostate cancer	0.000121	0.000389	CcSEcCtD
Quinapril—Pharyngitis—Epirubicin—prostate cancer	0.00012	0.000388	CcSEcCtD
Quinapril—Skin disorder—Capecitabine—prostate cancer	0.00012	0.000387	CcSEcCtD
Quinapril—Urinary tract disorder—Epirubicin—prostate cancer	0.00012	0.000386	CcSEcCtD
Quinapril—Hyperhidrosis—Capecitabine—prostate cancer	0.00012	0.000386	CcSEcCtD
Quinapril—Connective tissue disorder—Epirubicin—prostate cancer	0.000119	0.000384	CcSEcCtD
Quinapril—Urethral disorder—Epirubicin—prostate cancer	0.000119	0.000383	CcSEcCtD
Quinapril—Loss of consciousness—Prednisone—prostate cancer	0.000119	0.000383	CcSEcCtD
Quinapril—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000118	0.000381	CcSEcCtD
Quinapril—Dextropropoxyphene—CYP3A4—prostate cancer	0.000118	0.0188	CrCbGaD
Quinapril—Nausea—Estradiol—prostate cancer	0.000118	0.00038	CcSEcCtD
Quinapril—Vomiting—Mitoxantrone—prostate cancer	0.000118	0.000379	CcSEcCtD
Quinapril—Fentanyl—CYP3A4—prostate cancer	0.000117	0.0186	CrCbGaD
Quinapril—Agranulocytosis—Doxorubicin—prostate cancer	0.000117	0.000376	CcSEcCtD
Quinapril—Rash—Mitoxantrone—prostate cancer	0.000117	0.000376	CcSEcCtD
Quinapril—Dermatitis—Mitoxantrone—prostate cancer	0.000116	0.000375	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000116	0.000375	CcSEcCtD
Quinapril—Headache—Mitoxantrone—prostate cancer	0.000116	0.000373	CcSEcCtD
Quinapril—Insomnia—Docetaxel—prostate cancer	0.000116	0.000373	CcSEcCtD
Quinapril—Myalgia—Prednisone—prostate cancer	0.000115	0.000371	CcSEcCtD
Quinapril—Arthralgia—Prednisone—prostate cancer	0.000115	0.000371	CcSEcCtD
Quinapril—ACE—Peptide hormone metabolism—CTNNB1—prostate cancer	0.000115	0.00577	CbGpPWpGaD
Quinapril—Paraesthesia—Docetaxel—prostate cancer	0.000115	0.00037	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000114	0.000368	CcSEcCtD
Quinapril—Dyspnoea—Docetaxel—prostate cancer	0.000114	0.000367	CcSEcCtD
Quinapril—Somnolence—Docetaxel—prostate cancer	0.000114	0.000366	CcSEcCtD
Quinapril—Discomfort—Prednisone—prostate cancer	0.000114	0.000366	CcSEcCtD
Quinapril—Eye disorder—Epirubicin—prostate cancer	0.000113	0.000365	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000113	0.000363	CcSEcCtD
Quinapril—Cardiac disorder—Epirubicin—prostate cancer	0.000113	0.000363	CcSEcCtD
Quinapril—Dyspepsia—Docetaxel—prostate cancer	0.000113	0.000363	CcSEcCtD
Quinapril—Hepatitis—Doxorubicin—prostate cancer	0.000112	0.000362	CcSEcCtD
Quinapril—Insomnia—Capecitabine—prostate cancer	0.000112	0.000361	CcSEcCtD
Quinapril—Pharyngitis—Doxorubicin—prostate cancer	0.000111	0.000359	CcSEcCtD
Quinapril—Paraesthesia—Capecitabine—prostate cancer	0.000111	0.000358	CcSEcCtD
Quinapril—Urinary tract disorder—Doxorubicin—prostate cancer	0.000111	0.000357	CcSEcCtD
Quinapril—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00011	0.000356	CcSEcCtD
Quinapril—Asthenia—Etoposide—prostate cancer	0.00011	0.000356	CcSEcCtD
Quinapril—Connective tissue disorder—Doxorubicin—prostate cancer	0.00011	0.000356	CcSEcCtD
Quinapril—Dyspnoea—Capecitabine—prostate cancer	0.00011	0.000356	CcSEcCtD
Quinapril—Oedema—Prednisone—prostate cancer	0.00011	0.000355	CcSEcCtD
Quinapril—Anaphylactic shock—Prednisone—prostate cancer	0.00011	0.000355	CcSEcCtD
Quinapril—Fatigue—Docetaxel—prostate cancer	0.00011	0.000355	CcSEcCtD
Quinapril—Angiopathy—Epirubicin—prostate cancer	0.00011	0.000355	CcSEcCtD
Quinapril—Urethral disorder—Doxorubicin—prostate cancer	0.00011	0.000355	CcSEcCtD
Quinapril—Nausea—Mitoxantrone—prostate cancer	0.00011	0.000354	CcSEcCtD
Quinapril—Immune system disorder—Epirubicin—prostate cancer	0.00011	0.000353	CcSEcCtD
Quinapril—Infection—Prednisone—prostate cancer	0.00011	0.000353	CcSEcCtD
Quinapril—Mediastinal disorder—Epirubicin—prostate cancer	0.000109	0.000352	CcSEcCtD
Quinapril—Constipation—Docetaxel—prostate cancer	0.000109	0.000352	CcSEcCtD
Quinapril—Dyspepsia—Capecitabine—prostate cancer	0.000109	0.000351	CcSEcCtD
Quinapril—Pruritus—Etoposide—prostate cancer	0.000109	0.000351	CcSEcCtD
Quinapril—Shock—Prednisone—prostate cancer	0.000108	0.00035	CcSEcCtD
Quinapril—Arrhythmia—Epirubicin—prostate cancer	0.000108	0.000349	CcSEcCtD
Quinapril—Nervous system disorder—Prednisone—prostate cancer	0.000108	0.000348	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—RPL12—prostate cancer	0.000108	0.00542	CbGpPWpGaD
Quinapril—Tachycardia—Prednisone—prostate cancer	0.000108	0.000347	CcSEcCtD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000108	0.0054	CbGpPWpGaD
Quinapril—Alopecia—Epirubicin—prostate cancer	0.000107	0.000346	CcSEcCtD
Quinapril—Skin disorder—Prednisone—prostate cancer	0.000107	0.000345	CcSEcCtD
Quinapril—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000107	0.000344	CcSEcCtD
Quinapril—Fatigue—Capecitabine—prostate cancer	0.000107	0.000344	CcSEcCtD
Quinapril—Hyperhidrosis—Prednisone—prostate cancer	0.000107	0.000343	CcSEcCtD
Quinapril—Mental disorder—Epirubicin—prostate cancer	0.000106	0.000343	CcSEcCtD
Quinapril—Constipation—Capecitabine—prostate cancer	0.000106	0.000341	CcSEcCtD
Quinapril—Feeling abnormal—Docetaxel—prostate cancer	0.000105	0.000339	CcSEcCtD
Quinapril—Diarrhoea—Etoposide—prostate cancer	0.000105	0.000339	CcSEcCtD
Quinapril—Eye disorder—Doxorubicin—prostate cancer	0.000105	0.000338	CcSEcCtD
Quinapril—Gastrointestinal pain—Docetaxel—prostate cancer	0.000105	0.000337	CcSEcCtD
Quinapril—Cardiac disorder—Doxorubicin—prostate cancer	0.000104	0.000336	CcSEcCtD
Quinapril—Flatulence—Epirubicin—prostate cancer	0.000104	0.000335	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000104	0.00523	CbGpPWpGaD
Quinapril—Tension—Epirubicin—prostate cancer	0.000104	0.000334	CcSEcCtD
Quinapril—Nervousness—Epirubicin—prostate cancer	0.000103	0.000331	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—HSP90B1—prostate cancer	0.000102	0.00514	CbGpPWpGaD
Quinapril—Back pain—Epirubicin—prostate cancer	0.000102	0.000329	CcSEcCtD
Quinapril—Feeling abnormal—Capecitabine—prostate cancer	0.000102	0.000329	CcSEcCtD
Quinapril—Angiopathy—Doxorubicin—prostate cancer	0.000102	0.000328	CcSEcCtD
Quinapril—Dizziness—Etoposide—prostate cancer	0.000102	0.000328	CcSEcCtD
Quinapril—Immune system disorder—Doxorubicin—prostate cancer	0.000101	0.000327	CcSEcCtD
Quinapril—Gastrointestinal pain—Capecitabine—prostate cancer	0.000101	0.000326	CcSEcCtD
Quinapril—Mediastinal disorder—Doxorubicin—prostate cancer	0.000101	0.000326	CcSEcCtD
Quinapril—Abdominal pain—Docetaxel—prostate cancer	0.000101	0.000326	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Prednisone—prostate cancer	0.0001	0.000324	CcSEcCtD
Quinapril—Arrhythmia—Doxorubicin—prostate cancer	0.0001	0.000323	CcSEcCtD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	9.98e-05	0.00502	CbGpPWpGaD
Quinapril—Insomnia—Prednisone—prostate cancer	9.97e-05	0.000321	CcSEcCtD
Quinapril—Alopecia—Doxorubicin—prostate cancer	9.92e-05	0.00032	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—EIF3A—prostate cancer	9.91e-05	0.00498	CbGpPWpGaD
Quinapril—Paraesthesia—Prednisone—prostate cancer	9.9e-05	0.000319	CcSEcCtD
Quinapril—Mental disorder—Doxorubicin—prostate cancer	9.84e-05	0.000317	CcSEcCtD
Quinapril—Ill-defined disorder—Epirubicin—prostate cancer	9.8e-05	0.000316	CcSEcCtD
Quinapril—Abdominal pain—Capecitabine—prostate cancer	9.78e-05	0.000315	CcSEcCtD
Quinapril—Vomiting—Etoposide—prostate cancer	9.78e-05	0.000315	CcSEcCtD
Quinapril—Dyspepsia—Prednisone—prostate cancer	9.7e-05	0.000313	CcSEcCtD
Quinapril—Rash—Etoposide—prostate cancer	9.7e-05	0.000313	CcSEcCtD
Quinapril—Dermatitis—Etoposide—prostate cancer	9.69e-05	0.000312	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	9.66e-05	0.00485	CbGpPWpGaD
Quinapril—Headache—Etoposide—prostate cancer	9.64e-05	0.000311	CcSEcCtD
Quinapril—Flatulence—Doxorubicin—prostate cancer	9.63e-05	0.00031	CcSEcCtD
Quinapril—Tension—Doxorubicin—prostate cancer	9.59e-05	0.000309	CcSEcCtD
Quinapril—Malaise—Epirubicin—prostate cancer	9.53e-05	0.000307	CcSEcCtD
Quinapril—Fatigue—Prednisone—prostate cancer	9.5e-05	0.000306	CcSEcCtD
Quinapril—Nervousness—Doxorubicin—prostate cancer	9.49e-05	0.000306	CcSEcCtD
Quinapril—Vertigo—Epirubicin—prostate cancer	9.49e-05	0.000306	CcSEcCtD
Quinapril—Syncope—Epirubicin—prostate cancer	9.47e-05	0.000305	CcSEcCtD
Quinapril—Back pain—Doxorubicin—prostate cancer	9.45e-05	0.000305	CcSEcCtD
Quinapril—Constipation—Prednisone—prostate cancer	9.43e-05	0.000304	CcSEcCtD
Quinapril—Palpitations—Epirubicin—prostate cancer	9.34e-05	0.000301	CcSEcCtD
Quinapril—Loss of consciousness—Epirubicin—prostate cancer	9.28e-05	0.000299	CcSEcCtD
Quinapril—Cough—Epirubicin—prostate cancer	9.22e-05	0.000297	CcSEcCtD
Quinapril—Asthenia—Docetaxel—prostate cancer	9.17e-05	0.000296	CcSEcCtD
Quinapril—Nausea—Etoposide—prostate cancer	9.14e-05	0.000294	CcSEcCtD
Quinapril—Feeling abnormal—Prednisone—prostate cancer	9.08e-05	0.000293	CcSEcCtD
Quinapril—Ill-defined disorder—Doxorubicin—prostate cancer	9.07e-05	0.000292	CcSEcCtD
Quinapril—Pruritus—Docetaxel—prostate cancer	9.04e-05	0.000291	CcSEcCtD
Quinapril—Gastrointestinal pain—Prednisone—prostate cancer	9.01e-05	0.000291	CcSEcCtD
Quinapril—Myalgia—Epirubicin—prostate cancer	8.99e-05	0.00029	CcSEcCtD
Quinapril—Chest pain—Epirubicin—prostate cancer	8.99e-05	0.00029	CcSEcCtD
Quinapril—Arthralgia—Epirubicin—prostate cancer	8.99e-05	0.00029	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.93e-05	0.000288	CcSEcCtD
Quinapril—Discomfort—Epirubicin—prostate cancer	8.89e-05	0.000286	CcSEcCtD
Quinapril—Asthenia—Capecitabine—prostate cancer	8.88e-05	0.000286	CcSEcCtD
Quinapril—Malaise—Doxorubicin—prostate cancer	8.81e-05	0.000284	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—MME—prostate cancer	8.8e-05	0.00442	CbGpPWpGaD
Quinapril—Dry mouth—Epirubicin—prostate cancer	8.8e-05	0.000283	CcSEcCtD
Quinapril—Vertigo—Doxorubicin—prostate cancer	8.78e-05	0.000283	CcSEcCtD
Quinapril—Syncope—Doxorubicin—prostate cancer	8.77e-05	0.000282	CcSEcCtD
Quinapril—Pruritus—Capecitabine—prostate cancer	8.76e-05	0.000282	CcSEcCtD
Quinapril—Diarrhoea—Docetaxel—prostate cancer	8.75e-05	0.000282	CcSEcCtD
Quinapril—Abdominal pain—Prednisone—prostate cancer	8.71e-05	0.000281	CcSEcCtD
Quinapril—Palpitations—Doxorubicin—prostate cancer	8.64e-05	0.000278	CcSEcCtD
Quinapril—Anaphylactic shock—Epirubicin—prostate cancer	8.62e-05	0.000278	CcSEcCtD
Quinapril—Oedema—Epirubicin—prostate cancer	8.62e-05	0.000278	CcSEcCtD
Quinapril—Loss of consciousness—Doxorubicin—prostate cancer	8.59e-05	0.000277	CcSEcCtD
Quinapril—Infection—Epirubicin—prostate cancer	8.57e-05	0.000276	CcSEcCtD
Quinapril—Cough—Doxorubicin—prostate cancer	8.53e-05	0.000275	CcSEcCtD
Quinapril—Shock—Epirubicin—prostate cancer	8.48e-05	0.000273	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	8.48e-05	0.00426	CbGpPWpGaD
Quinapril—Diarrhoea—Capecitabine—prostate cancer	8.47e-05	0.000273	CcSEcCtD
Quinapril—Nervous system disorder—Epirubicin—prostate cancer	8.45e-05	0.000272	CcSEcCtD
Quinapril—Dizziness—Docetaxel—prostate cancer	8.45e-05	0.000272	CcSEcCtD
Quinapril—Thrombocytopenia—Epirubicin—prostate cancer	8.44e-05	0.000272	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—GRP—prostate cancer	8.43e-05	0.00423	CbGpPWpGaD
Quinapril—Tachycardia—Epirubicin—prostate cancer	8.41e-05	0.000271	CcSEcCtD
Quinapril—Skin disorder—Epirubicin—prostate cancer	8.37e-05	0.00027	CcSEcCtD
Quinapril—Hyperhidrosis—Epirubicin—prostate cancer	8.33e-05	0.000269	CcSEcCtD
Quinapril—Chest pain—Doxorubicin—prostate cancer	8.32e-05	0.000268	CcSEcCtD
Quinapril—Arthralgia—Doxorubicin—prostate cancer	8.32e-05	0.000268	CcSEcCtD
Quinapril—Myalgia—Doxorubicin—prostate cancer	8.32e-05	0.000268	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	8.27e-05	0.00415	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	8.27e-05	0.00415	CbGpPWpGaD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.26e-05	0.000266	CcSEcCtD
Quinapril—Discomfort—Doxorubicin—prostate cancer	8.22e-05	0.000265	CcSEcCtD
Quinapril—Dizziness—Capecitabine—prostate cancer	8.18e-05	0.000264	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—RPL10—prostate cancer	8.18e-05	0.00411	CbGpPWpGaD
Quinapril—Dry mouth—Doxorubicin—prostate cancer	8.14e-05	0.000262	CcSEcCtD
Quinapril—Vomiting—Docetaxel—prostate cancer	8.13e-05	0.000262	CcSEcCtD
Quinapril—Rash—Docetaxel—prostate cancer	8.06e-05	0.00026	CcSEcCtD
Quinapril—Dermatitis—Docetaxel—prostate cancer	8.05e-05	0.000259	CcSEcCtD
Quinapril—Headache—Docetaxel—prostate cancer	8.01e-05	0.000258	CcSEcCtD
Quinapril—Oedema—Doxorubicin—prostate cancer	7.98e-05	0.000257	CcSEcCtD
Quinapril—Anaphylactic shock—Doxorubicin—prostate cancer	7.98e-05	0.000257	CcSEcCtD
Quinapril—Infection—Doxorubicin—prostate cancer	7.93e-05	0.000255	CcSEcCtD
Quinapril—Asthenia—Prednisone—prostate cancer	7.91e-05	0.000255	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	7.87e-05	0.00396	CbGpPWpGaD
Quinapril—Vomiting—Capecitabine—prostate cancer	7.87e-05	0.000254	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Epirubicin—prostate cancer	7.85e-05	0.000253	CcSEcCtD
Quinapril—Shock—Doxorubicin—prostate cancer	7.85e-05	0.000253	CcSEcCtD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	7.85e-05	0.00394	CbGpPWpGaD
Quinapril—Nervous system disorder—Doxorubicin—prostate cancer	7.82e-05	0.000252	CcSEcCtD
Quinapril—Thrombocytopenia—Doxorubicin—prostate cancer	7.81e-05	0.000252	CcSEcCtD
Quinapril—Rash—Capecitabine—prostate cancer	7.8e-05	0.000251	CcSEcCtD
Quinapril—Pruritus—Prednisone—prostate cancer	7.8e-05	0.000251	CcSEcCtD
Quinapril—Insomnia—Epirubicin—prostate cancer	7.8e-05	0.000251	CcSEcCtD
Quinapril—Dermatitis—Capecitabine—prostate cancer	7.8e-05	0.000251	CcSEcCtD
Quinapril—Tachycardia—Doxorubicin—prostate cancer	7.79e-05	0.000251	CcSEcCtD
Quinapril—Headache—Capecitabine—prostate cancer	7.75e-05	0.00025	CcSEcCtD
Quinapril—Skin disorder—Doxorubicin—prostate cancer	7.75e-05	0.00025	CcSEcCtD
Quinapril—Paraesthesia—Epirubicin—prostate cancer	7.74e-05	0.000249	CcSEcCtD
Quinapril—Hyperhidrosis—Doxorubicin—prostate cancer	7.71e-05	0.000249	CcSEcCtD
Quinapril—Dyspnoea—Epirubicin—prostate cancer	7.69e-05	0.000248	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	7.67e-05	0.00385	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	7.67e-05	0.00385	CbGpPWpGaD
Quinapril—Somnolence—Epirubicin—prostate cancer	7.66e-05	0.000247	CcSEcCtD
Quinapril—Nausea—Docetaxel—prostate cancer	7.59e-05	0.000245	CcSEcCtD
Quinapril—Dyspepsia—Epirubicin—prostate cancer	7.59e-05	0.000245	CcSEcCtD
Quinapril—Diarrhoea—Prednisone—prostate cancer	7.54e-05	0.000243	CcSEcCtD
Quinapril—Gastrointestinal disorder—Epirubicin—prostate cancer	7.44e-05	0.00024	CcSEcCtD
Quinapril—Fatigue—Epirubicin—prostate cancer	7.43e-05	0.00024	CcSEcCtD
Quinapril—Constipation—Epirubicin—prostate cancer	7.37e-05	0.000238	CcSEcCtD
Quinapril—Nausea—Capecitabine—prostate cancer	7.35e-05	0.000237	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—ATF3—prostate cancer	7.34e-05	0.00369	CbGpPWpGaD
Quinapril—Dizziness—Prednisone—prostate cancer	7.29e-05	0.000235	CcSEcCtD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	7.28e-05	0.00366	CbGpPWpGaD
Quinapril—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.27e-05	0.000234	CcSEcCtD
Quinapril—Insomnia—Doxorubicin—prostate cancer	7.22e-05	0.000233	CcSEcCtD
Quinapril—Paraesthesia—Doxorubicin—prostate cancer	7.16e-05	0.000231	CcSEcCtD
Quinapril—Dyspnoea—Doxorubicin—prostate cancer	7.11e-05	0.000229	CcSEcCtD
Quinapril—Feeling abnormal—Epirubicin—prostate cancer	7.1e-05	0.000229	CcSEcCtD
Quinapril—Somnolence—Doxorubicin—prostate cancer	7.09e-05	0.000229	CcSEcCtD
Quinapril—Gastrointestinal pain—Epirubicin—prostate cancer	7.05e-05	0.000227	CcSEcCtD
Quinapril—Dyspepsia—Doxorubicin—prostate cancer	7.02e-05	0.000226	CcSEcCtD
Quinapril—Vomiting—Prednisone—prostate cancer	7.01e-05	0.000226	CcSEcCtD
Quinapril—Rash—Prednisone—prostate cancer	6.95e-05	0.000224	CcSEcCtD
Quinapril—Dermatitis—Prednisone—prostate cancer	6.94e-05	0.000224	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—IGFBP3—prostate cancer	6.91e-05	0.00347	CbGpPWpGaD
Quinapril—Headache—Prednisone—prostate cancer	6.91e-05	0.000223	CcSEcCtD
Quinapril—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.89e-05	0.000222	CcSEcCtD
Quinapril—Fatigue—Doxorubicin—prostate cancer	6.88e-05	0.000222	CcSEcCtD
Quinapril—Constipation—Doxorubicin—prostate cancer	6.82e-05	0.00022	CcSEcCtD
Quinapril—Abdominal pain—Epirubicin—prostate cancer	6.82e-05	0.00022	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—ACHE—prostate cancer	6.75e-05	0.00339	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	6.7e-05	0.00337	CbGpPWpGaD
Quinapril—Feeling abnormal—Doxorubicin—prostate cancer	6.57e-05	0.000212	CcSEcCtD
Quinapril—Nausea—Prednisone—prostate cancer	6.55e-05	0.000211	CcSEcCtD
Quinapril—Gastrointestinal pain—Doxorubicin—prostate cancer	6.52e-05	0.00021	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—RPS19—prostate cancer	6.49e-05	0.00326	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—CTSD—prostate cancer	6.39e-05	0.00321	CbGpPWpGaD
Quinapril—Abdominal pain—Doxorubicin—prostate cancer	6.31e-05	0.000203	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—THBS1—prostate cancer	6.29e-05	0.00316	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	6.22e-05	0.00313	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	6.19e-05	0.00311	CbGpPWpGaD
Quinapril—Asthenia—Epirubicin—prostate cancer	6.19e-05	0.000199	CcSEcCtD
Quinapril—Pruritus—Epirubicin—prostate cancer	6.1e-05	0.000197	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—CALR—prostate cancer	5.98e-05	0.003	CbGpPWpGaD
Quinapril—Diarrhoea—Epirubicin—prostate cancer	5.9e-05	0.00019	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	5.74e-05	0.00289	CbGpPWpGaD
Quinapril—Asthenia—Doxorubicin—prostate cancer	5.72e-05	0.000184	CcSEcCtD
Quinapril—Dizziness—Epirubicin—prostate cancer	5.7e-05	0.000184	CcSEcCtD
Quinapril—Pruritus—Doxorubicin—prostate cancer	5.64e-05	0.000182	CcSEcCtD
Quinapril—Vomiting—Epirubicin—prostate cancer	5.48e-05	0.000177	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	5.47e-05	0.00275	CbGpPWpGaD
Quinapril—Diarrhoea—Doxorubicin—prostate cancer	5.46e-05	0.000176	CcSEcCtD
Quinapril—Rash—Epirubicin—prostate cancer	5.44e-05	0.000175	CcSEcCtD
Quinapril—Dermatitis—Epirubicin—prostate cancer	5.43e-05	0.000175	CcSEcCtD
Quinapril—Headache—Epirubicin—prostate cancer	5.4e-05	0.000174	CcSEcCtD
Quinapril—Dizziness—Doxorubicin—prostate cancer	5.28e-05	0.00017	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	5.2e-05	0.00261	CbGpPWpGaD
Quinapril—Nausea—Epirubicin—prostate cancer	5.12e-05	0.000165	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—PLAUR—prostate cancer	5.11e-05	0.00257	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	5.07e-05	0.00255	CbGpPWpGaD
Quinapril—Vomiting—Doxorubicin—prostate cancer	5.07e-05	0.000163	CcSEcCtD
Quinapril—Rash—Doxorubicin—prostate cancer	5.03e-05	0.000162	CcSEcCtD
Quinapril—Dermatitis—Doxorubicin—prostate cancer	5.03e-05	0.000162	CcSEcCtD
Quinapril—Headache—Doxorubicin—prostate cancer	5e-05	0.000161	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	4.82e-05	0.00242	CbGpPWpGaD
Quinapril—Nausea—Doxorubicin—prostate cancer	4.74e-05	0.000153	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.43e-05	0.00223	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.18e-05	0.0021	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.11e-05	0.00207	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.99e-05	0.002	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.88e-05	0.00195	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.7e-05	0.00186	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—LEP—prostate cancer	3.54e-05	0.00178	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.52e-05	0.00177	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	3.35e-05	0.00168	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.27e-05	0.00164	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	3.11e-05	0.00156	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—INS—prostate cancer	3.02e-05	0.00152	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—IGF1—prostate cancer	2.92e-05	0.00147	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—MMP2—prostate cancer	2.83e-05	0.00142	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.56e-05	0.00129	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.37e-05	0.00119	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—CXCL8—prostate cancer	2.35e-05	0.00118	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—CTNNB1—prostate cancer	2.17e-05	0.00109	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.03e-05	0.00102	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.89e-05	0.000947	CbGpPWpGaD
